Damaged proteins bearing l-isoaspartyl residues and aging: A dynamic equilibrium between generation of isomerized forms and repair by pimt

Current Aging Science

Volumn 4, Issue 1, 2011, Pages 8-18

  Desrosiers, Richard R ^a   Fanélus, Irvens ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Aging; Damaged proteins; L isoaspartyl residues; PIMT

Indexed keywords

ALPHA CRYSTALLIN; ALPHA SYNUCLEIN; ALPHA TUBULIN; AMYLOID BETA PROTEIN; BETA SYNUCLEIN; BETA TUBULIN; COMPLEMENTARY DNA; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ENZYME; ESTRADIOL; FIBRONECTIN; INTEGRIN; MESSENGER RNA; METHYLTRANSFERASE; PROTEASOME; PROTEIN ISOASPARTYL METHYLTRANSFERASE; S ADENOSYLMETHIONINE; SOMATOMEDIN C; UNCLASSIFIED DRUG; ISOASPARTIC ACID; PCMT1 PROTEIN, HUMAN; PROTEIN; PROTEIN DEXTRO ASPARTATE METHYLTRANSFERASE;

AGING; ALZHEIMER DISEASE; AMNION FLUID; BREAST CANCER; CELL MIGRATION; CELL ORGANELLE; CELL SURVIVAL; CEREBROSPINAL FLUID; COGNITION; CORPUS STRIATUM; CYTOSKELETON; DEAMINATION; DEGENERATIVE DISEASE; DENTATE GYRUS; DOWN REGULATION; DOWN SYNDROME; ENZYME ACTIVITY; FRONTAL CORTEX; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; ISOMERIZATION; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MISSENSE MUTATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEOMICS; REVIEW; SUBICULUM; SYNAPTIC TRANSMISSION; TISSUE DISTRIBUTION; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN PROCESSING;

AGING; HUMANS; ISOASPARTIC ACID; NEURODEGENERATIVE DISEASES; NEURONS; PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS;

EID: 79958792815     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609811104010008     Document Type: Review

References (91)

1. Cloos PA and Christgau S. Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity. Biogerontology 2004; 5(3): 139-158.
2. Lanthier J and Desrosiers RR. Protein L-isoaspartyl methyltransferase repairs abnormal aspartyl residues accumulated in vivo in type-I collagen and restores cell migration. Exp Cell Res 2004; 293: 96-105.
3. Clarke S. Aging as war between chemical and biochemical processes: protein methylation and the recognition of age-damaged proteins for repair. Ageing Res Rev 2003; 2(3): 263-285.
4. Shimuzu T, Matsuoka Y and Shirasawa T. Biological significance of isoaspartate and its repair system. Biol Pharm Bull 2004; 28: 1590-1596.
5. Gupta R and Srivastava OP. Effect of deamidation of asparagine 146 on functional and structural properties of human lens alphaBcrystallin. Invest Ophthalmol Vis Sci 2004a; 45(1): 206-214.
6. Gupta R and Srivastava OP. Deamidation affects structural and functional properties of human alphaA-crystallin and its oligomerization with alphaB-crystallin. J Biol Chem 2004b; 279(43): 44258-44269.
7. Sharma KK and Santhoshkumar P. Lens aging: effects of crystallins. Biochim Biophys Acta 2009; 1790(10): 1095-1108.
8. Kinzel V, König N, Pipkorn R, Bossemeyer D and Lehmann WD. The amino terminus of PKA catalytic subunit--a site for introduction of posttranslational heterogeneities by deamidation: D-Asp2 and D-isoAsp2 containing isozymes. Protein Sci 2000; 9(11): 2269-2277.
9. Pepperkok R, Hotz-Wagenblatt A, König N, Girod A, Bossemeyer D and Kinzel V. Intracellular distribution of mammalian protein kinase A catalytic subunit altered by conserved Asn2 deamidation. J Cell Biol 2000; 148(4): 715-726.
10. Curnis F, Longhi R, Crippa L, Cattaneo A, Dondossola E, Bachi A, et al. Spontaneous formation of L-isoaspartate and gain of function in fibronectin. J Biol Chem 2006; 281(47): 36466-36476.
11. Reissner, KJ and Aswad DW. Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals? Cell Mol Life Sci 2003; 60(7): 1281-1295.
12. Ingrosso D, Fowler AV, Bleibaum J and Clarke S. Sequence of the D-aspartyl/L-isoaspartyl protein methyltransferase from human erythrocytes. Common sequence motifs for protein, DNA, RNA, and small molecule S-adenosylmethionine-dependent methyltransferases. J Biol Chem 1989; 264(33): 20131-20139.
13. Kharbanda KK, Mailliard ME, Baldwin CR, Sorrell MF and Tuma DJ. Accumulation of proteins bearing atypical isoaspartyl residues in livers of alcohol-fed rats is prevented by betaine administration: effects on protein-L-isoaspartyl methyltransferase activity. J Hepatol 2007; 46(6): 1119-25.
14. Perlman DH, Bauer SM, Ashrafian H, Bryan NS, Garcia-Saura MF, Lim CC, et al. Mechanistic insights into nitrite-induced cardioprotection using an integrated metabolomic/proteomic approach. Circ Res 2009; 104(6): 796-804.
15. O'Connor CM. Regulation and subcellular distribution of a protein methyltransferase and its damaged aspartyl substrate sites in developing Xenopus oocytes. J Biol Chem 1987; 262(21): 10398-403.
16. Sellinger OZ, Kramer CM, Fischer-Bovenkerk C and Adams CM. The characterization of a membrane-bound protein carboxymethylation system in brain. Neurochem Int 1987; 10(2): 155-66.
17. Boivin D, Bilodeau D and Béliveau R. Immunochemical characterization of L-isoaspartyl-protein carboxyl methyltransferase from mammalian tissues. Biochem J 1995; 309(Pt 3): 993-8.
18. Cueille N, Blanc CT, Riederer IM and Riederer BM. Microtubuleassociated protein 1B binds glyceraldehyde-3-phosphate dehydrogenase. J Proteome Res 2007; 6(7): 2640-7.
19. Molina H, Bunkenborg J, Reddy GH, Muthusamy B, Scheel PJ and Pandey A. A proteomic analysis of human hemodialysis fluid. Mol Cell Proteomics 2005; 4(5): 637-50.
20. Cortesi L, Barchetti A, De Matteis E, Rossi E, Della Casa L, Marcheselli L, et al. Identification of protein clusters predictive of response to chemotherapy in breast cancer patients. J Proteome Res 2009; 8(11): 4916-33.
21. Burgess JA, Lescuyer P, Hainard A, Burkhard PR, Turck N, Michel P, et al. Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid. J Proteome Res 2006; 5(7): 1674-81.
22. Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, et al. Functional genomic analysis of amniotic fluid cellfree mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci USA 2009; 106(23): 9425-9.
23. EJ Jr and Axelrod J. Regional and subcellular distribution of protein carboxymethylase in brain and other tissues. J Neurochem 1976; 26(6): 1159-65.
24. Mizobuchi M, Murao K, Takeda R and Kakimoto Y. Tissuespecific expression of isoaspartyl protein carboxyl methyltransferase gene in rat brain and testis. J Neurochem 1994; 62(1): 322-8.
25. Fountoulakis M, Tsangaris GT, Maris A and Lubec G. The rat brain hippocampus proteome. Chromatogr B Anal Technol Biomed Life Sci 2005; 819(1): 115-29.
26. Marais L, Hattingh SM, Stein DJ and Daniels WM. A proteomic analysis of the ventral hippocampus of rats subjected to maternal separation and escitalopram treatment. Metab Brain Dis 2009; 24(4): 569-86.
27. Billingsley ML, Kim S and Kuhn DM. Immunohistochemical localization of protein-O-carboxylmethyltransferase in rat brain neurons. Neuroscience 1985; 15(1): 159-71.
28. Faure JJ, Hattingh SM, Stein DJ and Daniels WM. Proteomic analysis reveals differentially expressed proteins in the rat frontal cortex after methamphetamine treatment. Metab Brain Dis 2009; 24(4): 685-700.
29. O'Brien E, Dedova I, Duffy L, Cordwell S, Karl T and Matsumoto I. Effects of chronic risperidone treatment on the striatal protein profiles in rats. Brain Res 2006; 1113(1): 24-32.
30. Pozzi Mucelli S, Odreman F, Gonzales ML, Gerardi E, Stanta G and Vindigni A. Proteomic studies on the white matter of human brain. J Chromatogr B Anal Technol Biomed Life Sci 2006; 833(1): 80-90.
31. Dumont D, Noben JP, Verhaert P, Stinissen P and Robben J. Gelfree analysis of the human brain proteome: application of liquid chromatography and mass spectrometry on biopsy and autopsy samples. Proteomics 2006; 6(18): 4967-77.
32. Fountoulakis M, Juranville JF, Dierssen M and Lubec G. Proteomic analysis of the fetal brain. Proteomics 2002; 2(11): 1547-76.
33. Odreman F, Vindigni M, Gonzales ML, Niccolini B, Candiano G, Zanotti B, et al. Proteomic studies on low- and high-grade human brain astrocytomas. J Proteome Res 2005; 4(3): 698-708.
34. Khalil AA. Biomarker discovery: a proteomic approach for brain cancer profiling. Cancer Sci 2007; 98(2): 201-13.
35. Martins-de-Souza D, Gattaz WF, Schmitt A, Maccarrone G, Hunyadi- Gulyás E, Eberlin MN, et al. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J Psychiatr Res 2009; 43(11): 978-86.
36. English JA, Dicker P, Föcking M, Dunn MJ and Cotter DR. 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease. Proteomics 2009; 9(12): 3368-82.
37. Chen W, Ji J and Ru B. Proteomic analysis of corticobasal degeneration: a case study of corticobasal degeneration at the proteome level. J Neuropsychiatry Clin Neurosci 2005; 17(3): 364-71.
38. Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, et al. Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 2006 15; 15(6): 965-77.
39. Billingsley ML and Balaban CD. Protein-O-carboxylmethyltransferase in the rat brain: high regional levels in the substantia nigra, locus coeruleus and paraventricular nucleus. Brain Res 1985; 358(1-2): 96-103.
40. Shirasawa T, Endoh R, Zeng YX, Sakamoto K and Mori H. Protein L-isoaspartyl methyltransferase: developmentally regulated gene expression and protein localization in the central nervous system of aged rat. Neurosci Lett 1995; 188(1): 37-40.
41. Baumgärtel K, Tweedie-Cullen RY, Grossmann J, Gehrig P, Livingstone- Zatchej M and Mansuy IM. Changes in the proteome after neuronal zif268 overexpression. J Proteome Res 2009; 8(7): 3298-316.
42. Witzmann FA, Arnold RJ, Bai F, Hrncirova P, Kimpel MW, Mechref YS, et al. A proteomic survey of rat cerebral cortical synaptosomes. Proteomics 2005; 5(8): 2177-201.
43. Etheridge N, Lewohl JM, Mayfield RD, Harris RA and Dodd PR. Synaptic proteome changes in the superior frontal gyrus and occipital cortex of the alcoholic brain. Proteomics Clin Appl 2009; 3(6): 730-42.
44. Ikegaya Y, Yamada M, Fukuda T, Kuroyanagi H, Shirasawa T and Nishiyama, N. Aberrant synaptic transmission in the hippocampal CA3 region and cognitive deterioration in protein-repair enzymedeficient mice. Hippocampus 2001; 11(3): 287-98.
45. Johnson BA and Aswad DW. Identification and topography of substrates for protein carboxyl methyltransferase in synaptic membrane and myelin-enriched fractions of bovine and rat brain. J Neurochem 1985; 45(4): 1119-27.
46. Vigneswara V, Lowenson JD, Powell CD, Thakur M, Bailey K, Clarke S, et al. Proteomic identification of novel substrates of a protein isoaspartyl methyltransferase repair enzyme. J Biol Chem 2006; 281(43): 32619-29.
47. Zhu JX, Doyle HA, Mamula MJ and Aswad DW. Protein repair in the brain, proteomic analysis of endogenous substrates for protein L-isoaspartyl methyltransferase in mouse brain. J Biol Chem 2006; 281(44): 33802-13.
48. Cookson MR. alpha-Synuclein and neuronal cell death. Mol Neurodegener 2009; 4: 9.
49. Ohtake H, Limprasert P, Fan Y, Onodera O, Kakita A, Takahashi H, et al. Beta-synuclein gene alterations in dementia with Lewy bodies. Neurology 2004; 63(5): 805-11.
50. Robinson NE, Robinson ML, Schulze SE, Lai BT and Gray HB. Deamidation of alpha-synuclein. Protein Sci 2009; 18(8): 1766-73.
51. Hye-Ryan L and Gil-Ja J. Age-Related Changes of Protein Carboxyl Methylation in Rat Brain and Liver. Korean Biochem J 1991; 24(1): 65-70.
52. Pelletier J, Desrosiers RR and Béliveau R. Age-related changes in carboxyl methylation of proteins in the kidney. Mech Ageing Dev 1996; 86(2): 115-35.
53. Ghandour H, Lin BF, Choi SW, Mason JB and Selhub J. Folate status and age affect the accumulation of L-isoaspartyl residues in rat liver proteins. J Nutr 2002; 132(6): 1357-60.
54. Johnson BA, Shirokawa JM, Geddes JW, Choi BH, Kim RC and Aswad DW. Protein L-isoaspartyl methyltransferase in postmortem brains of aged humans. Neurobiol Aging 1991; 12(1): 19-24.
55. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004; 429(6994): 883-91.
56. Visala Rao D, Boyle GM, Parsons PG, Watson K and Jones GL. Influence of ageing, heat shock treatment and in vivo total antioxidant status on gene-expression profile and protein synthesis in human peripheral lymphocytes. Mech Ageing Dev 2003; 124(1): 55-69.
57. McFadden PN and Clarke S. Protein carboxyl methyltransferase and methyl acceptor proteins in aging and cataractous tissue of the human eye lens. Mech Ageing Dev 1986; 34(1): 91-105.
58. Kodama T, Mizobuchi M, Takeda R, Torikai H, Shinomiya H and Ohashi Y. Hampered expression of isoaspartyl protein carboxyl methyltransferase gene in the human cataractous lens. Biochim Biophys Acta 1995; 1245(2): 269-72.
59. Christopher D and Edward BZ. Post-Transcriptional Regulation of Synaptic Vesicle Protein Expression and the Developmental Control of Synaptic Vesicle Formation. J Neurosci 1997; 17(7): 2365-75.
60. Safaei R and Fischer I. Turnover of cytoskeletal proteins in vivo. Brain Res 1990; 533(1): 83-90.
61. Najbauer J, Orpiszeeski J and Aswad DW. Molecular Aging of Tubulin: Accumulation of Isoaspartyl Sites in Vitro and in Vivo. Biochemistry 1996, 35916): 5183-90.
62. Lanthier J, Bouthillier A, Lapointe M, Demeule M, Béliveau R and Desrosiers RR. Down-regulation of protein L-isoaspartyl methyltransferase in human epileptic hippocampus contributes to generation of damaged tubulin. J Neurochem 2002, 83(3): 581-91.
63. Li W, Lesuisse C, Xu Y, Troncoso JC, Price DL, Lee MK. Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation. J Neurosci 2004; 24(33): 7400-9.
64. Perrin D, Soulage C, Pequignot JM and Géloën A. Resistance to obesity in Lou/C rats prevents ageing-associated metabolic alterations. Diabetologia 2003; 46(11): 1489-96.
65. Garcia-Segura LM, Diz-Chaves Y, Perez-Martin M and Darnaudéry M. Estradiol, insulin-like growth factor-I and brain aging. Psychoneuroendocrinology 2007; 32(Suppl 1): S57-61.
66. Jin Y, Yan EZ, Li XM, Fan Y, Zhao YJ, Liu Z, et al. Neuroprotective effect of sodium ferulate and signal transduction mechanisms in the aged rat hippocampus. Acta Pharmacol Sin 2008; 29(12): 1399-408.
67. Lamarre M and Desrosiers RR. Up-regulation of protein Lisoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization. Neuropharmacology 2008; 55(5): 669-76.
68. Cournoyer P and Desrosiers RR. Valproic acid enhances protein Lisoaspartyl methyltransferase expression by stimulating extracellular signal-regulated kinase signaling pathway. Neuropharmacology 2009; 56(5): 839-48.
69. D'Angelo S, Ingrosso D, Migliardi V, Sorrentino A, Donnarumma G, Baroni A, et al. Hydroxytyrosol, a natural antioxidant from olive oil, prevents protein damage induced by long-wave ultraviolet radiation in melanoma cells. Free Radic Biol Med 2005; 38(7): 908-19.
70. Dunlop RA, Brunk UT and Rodgers KJ. Oxidized proteins: mechanisms of removal and consequences of accumulation. IUBMB Life 2009; 61(5): 522-7.
71. Chondrogianni N and Gonos ES. Proteasome dysfunction in mammalian aging: steps and factors involved. Exp Gerontol 2005; 40(12): 931-8.
72. Lindquist JA and McFadden PN. Automethylation of protein (Daspartyl/ L-isoaspartyl) carboxyl methyltransferase, a response to enzyme aging. J Protein Chem 1994; 13(1): 23-30.
73. DeVry CG and Clarke S. Polymorphic forms of the protein Lisoaspartate (D-aspartate) O-methyltransferase involved in the repair of age-damaged proteins. J Hum Genet 1999; 44(5): 275-88.
74. Rutherford K and Daggett V. The V119I polymorphism in protein L-isoaspartate O-methyltransferase alters the substrate-binding interface. Protein Eng Des Sel 2009; 22(12): 713-21.
75. Watanabe A, Takio K and Ihara Y. Deamidation and isoaspartate formation in smeared tau in paired helical filaments. Unusual properties of the microtubule-binding domain of tau. J Biol Chem 1999; 274(11): 7368-78.
76. Shimizu T, Watanabe A, Ogawara M, Mori H and Shirasawa T. Isoaspartate formation and neurodegeneration in Alzheimer's disease. Arch Biochem Biophys 2000; 381(2): 225-34.
77. Goggins M, Scott JM and Weir DG. Methylation of cortical brain proteins from patients with HIV infection. Acta Neurol Scand 1999; 100(5): 326-31.
78. Payan IL, Chou SJ, Fisher GH, Man EH, Emory C and Frey WH 2nd. Altered aspartate in Alzheimer neurofibrillary tangles. Neurochem Res 1992; 17(2): 187-91.
79. Joseph S, Robbins K, Zhang W and Rekaya R. Effects of misdiagnosis in input data on the identification of differential expression genes in incipient Alzheimer patients. In Silico Biol 2008; 8(5-6): 545-54.
80. Kondo T, Shirasawa T, Itoyama Y and Mori H. Embryonic genes expressed in Alzheimer's disease brains. Neurosci Lett 1996; 209(3): 157-60.
81. Götz J and Götz NN. Animal models for Alzheimer's disease and frontotemporal dementia: a perspective. ASN Neuro 2009; 1(4): 251-64.
82. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, et al. Structural alterations in the peptide backbone of betaamyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993; 268(5): 3072-83.
83. Shimizu T, Fukuda H, Murayama S, Izumiyama N and Shirasawa T. Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease. J Neurosci Res 2002; 70(3): 451-61.
84. Fonseca MI, Head E, Velazquez P, Cotman CW and Tenner AJ. The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age. Exp Neurol 1999; 157(2): 277-88.
85. Hosoda R, Saido TC, Otvos L Jr, Arai T, Mann DM, Lee VM, et al. Quantification of modified amyloid beta peptides in Alzheimer disease and Down syndrome brains. J Neuropathol Exp Neurol 1998; 57(11): 1089-95.
86. Mori H, Ishii K, Tomiyama T, Furiya Y, Sahara N, Asano S, et al. Racemization: its biological significance on neuropathogenesis of Alzheimer's disease. Tohoku J Exp Med 1994; 174(3): 251-62.
87. Tomiyama T, Asano S, Furiya Y, Shirasawa T, Endo N and Mori H. Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues. J Biol Chem 1994; 269(14): 10205-8.
88. Chow VW, Mattson MP, Wong PC and Gleichmann M. An overview of APP processing enzymes and products. Neuromol Med 2010; 12(1): 1-12.
89. Böhme L, Bär JW, Hoffmann T, Manhart S, Ludwig HH, Rosche F, et al. Isoaspartate residues dramatically influence substrate recognition and turnover by proteases. Biol Chem 2008; 389(8): 1043-53.
90. Haque A, Banik NL and Ray SK. New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics. CNS Neurol Disord Drug Targets 2008; 7(3): 270-7.
91. Kagan RM and Clarke S. Widespread occurrence of three sequence motifs in diverse S-adenosylmethionine-dependent methyltransferases suggests a common structure for these enzymes. Arch Biochem Biophys 1994; 310(2): 417-27.